Search results

Order by most recent / most popular / relevance

Results: 1-10 of 17

Learned intermediary doctrine: Eleventh Circuit upholds summary judgment in favor of manufacturer in lawsuit claiming antidepressant caused suicide

Edwards Wildman Palmer LLP
-
USA
-
May 28 2010

The 11th Circuit Court of Appeals recently relied upon the learned intermediary doctrine in affirming summary judgment in favor of Smithkline Beecham Corp. (“SBC”) in a lawsuit claiming that the antidepressant Paxil caused the decedent to commit suicide

New York appellate court: claims against manufacturer of ear protectors

Edwards Wildman Palmer LLP
-
USA
-
September 29 2009

Earlier this month, a New York appellate court held that claims against the manufacturer of protective devices for ears were barred by the three-year statute of limitations governing actions to recover damages for personal injury

Chinese drywall - Senate bill could facilitate effecting service of process on foreign defendants

Edwards Wildman Palmer LLP
-
USA
-
August 28 2009

Legislation recently introduced in the United States Senate could help homeowners haul foreign manufacturers of allegedly defective Chinese drywall into court

California appellate court applies government contractor immunity defense to boilers on naval vessels in asbestos-related decision

Edwards Wildman Palmer LLP
-
USA
-
September 24 2009

Earlier this month, a California appellate court held that the government contractor immunity defense applies to a boiler manufactured to United States Navy specifications, shielding the manufacturer from a design defect claim

Federal judge issues default against Chinese drywall manufacturer

Edwards Wildman Palmer LLP
-
USA
-
September 29 2009

A federal judge in New Orleans has defaulted a defendant, Taishan Gypsum Company, in a products liability class action lawsuit

Botox maker files First Amendment suit against the FDA

Edwards Wildman Palmer LLP
-
USA
-
November 3 2009

Allergan, Inc., the maker of the drug Botox, recently filed suit against the Food & Drug Administration, alleging that certain FDA regulations unconstitutionally restrict Allergan’s truthful speech regarding off-label uses of its drug

Delaware court holds that endorsement requires exhaustion of separate retained limits for each lot or batch of contaminated peanut butter

Edwards Wildman Palmer LLP
-
USA
-
November 2 2009

Stephen Prignano and Denise Kraft, of Edwards Angell Palmer & Dodge, LLP, have obtained summary judgment for Lexington Insurance Company ("Lexington") in an insurance coverage dispute arising out of a salmonella outbreak caused by contaminated peanut butter

Chinese drywall first bellwether trial ongoing

Edwards Wildman Palmer LLP
-
USA
-
March 9 2010

The first federal trial in the nationwide Chinese drywall controversy began on February 19th, 2010 in New Orleans and is ongoing

Jury awards $141 million against Pfizer in connection with off-label use of Neurontin

Edwards Wildman Palmer LLP
-
USA
-
April 7 2010

A federal jury in Boston recently returned a verdict against Pfizer Inc. in connection with claims that Pfizer unlawfully promoted off-label uses of its anti-epilepsy drug Neurontin

Jury finds in favor of botox manufacturer in off-label use trial

Edwards Wildman Palmer LLP
-
USA
-
May 28 2010

A California jury recently returned a verdict in favor of Allergan, Inc., in a trial involving claims that Allergan’s promotion of an off-label use of its drug Botox caused the death of a pediatric patient suffering from cerebral palsy

next >